Trial Outcomes & Findings for Evaluation of Robotic Arm Rehabilitation in Stroke Patients (NCT NCT00333983)

NCT ID: NCT00333983

Last Updated: 2014-03-20

Results Overview

The Fugl-Meyer Assessment (FMA) is a stroke-specific, performance-based impairment index. It is designed to assess motor functioning, balance, sensation and joint functioning in patients with post-stroke hemiplegia (Fugl-Meyer, Jaasko, Leyman, Olsson, \& Steglind, 1975; Gladstone, Danells, \& Black, 2002). Sections can be administered separately and the upper extremity motor portion of this measure was used as our primary outcome. Assessment items included movement, coordination, and reflex action of the shoulder, elbow, forearm, wrist, and hand. These items were scored on the basis of ability to complete using a 3-point ordinal scale where 0=cannot perform, 1=performs partially and 2=performs fully. The total possible score for the upper extremity is 66 with a minimum range of 0 and maximum of 66. A higher score indicates a better outcome.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

62 participants

Primary outcome timeframe

Baseline to Final Training (6 weeks)

Results posted on

2014-03-20

Participant Flow

147 community-dwelling adults with a diagnosis of chronic stroke were referred for study criteria screening by local VA stroke clinics and PT/OT clinicians. Community study advertisements and flyers were also utulized during this recruitment period that started October 2006 and ended December 2009.

Participants were excluded prior to randomization if they did not meet inclusion/exclusion criteria. Some candidates declined after learning of the study length and schedule committment.

Participant milestones

Participant milestones
Measure
Planar Robot
Robot-assisted planar reaching x 60 minutes
Planar + Vertical Robot
Robot-assisted planar and robot-assisted vertical reaching x 60 minutes
Intensive Conventional Exercise
Upper extremity stretching, skateboard reaching activites, range of motion and arm ergometer x 60 minutes.
Overall Study
STARTED
20
21
21
Overall Study
COMPLETED
17
16
19
Overall Study
NOT COMPLETED
3
5
2

Reasons for withdrawal

Reasons for withdrawal
Measure
Planar Robot
Robot-assisted planar reaching x 60 minutes
Planar + Vertical Robot
Robot-assisted planar and robot-assisted vertical reaching x 60 minutes
Intensive Conventional Exercise
Upper extremity stretching, skateboard reaching activites, range of motion and arm ergometer x 60 minutes.
Overall Study
Lost to Follow-up
2
1
0
Overall Study
Adverse Event
1
1
1
Overall Study
Withdrawal by Subject
0
3
1

Baseline Characteristics

Evaluation of Robotic Arm Rehabilitation in Stroke Patients

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Planar Robot
n=20 Participants
Robot-assisted planar reaching x 60 minutes.
Planar + Vertical Robot
n=21 Participants
Robot-assisted planar and robot-assisted vertical reaching x 60 minutes.
Intensive Conventional Exercise
n=21 Participants
Upper extremity stretching, skateboard reaching activities, range of motion, and arm ergometer training x 60 minutes.
Total
n=62 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Age, Categorical
Between 18 and 65 years
16 Participants
n=5 Participants
17 Participants
n=7 Participants
19 Participants
n=5 Participants
52 Participants
n=4 Participants
Age, Categorical
>=65 years
4 Participants
n=5 Participants
4 Participants
n=7 Participants
2 Participants
n=5 Participants
10 Participants
n=4 Participants
Age, Continuous
57 years
STANDARD_DEVIATION 12 • n=5 Participants
60 years
STANDARD_DEVIATION 13 • n=7 Participants
56 years
STANDARD_DEVIATION 6.3 • n=5 Participants
57 years
STANDARD_DEVIATION 11 • n=4 Participants
Sex: Female, Male
Female
8 Participants
n=5 Participants
9 Participants
n=7 Participants
11 Participants
n=5 Participants
28 Participants
n=4 Participants
Sex: Female, Male
Male
12 Participants
n=5 Participants
12 Participants
n=7 Participants
10 Participants
n=5 Participants
34 Participants
n=4 Participants
Region of Enrollment
United States
20 participants
n=5 Participants
21 participants
n=7 Participants
21 participants
n=5 Participants
62 participants
n=4 Participants
Fugl-Meyer Upper Extremity Motor Assessment
20.3 units on a scale
STANDARD_DEVIATION 14.7 • n=5 Participants
16.5 units on a scale
STANDARD_DEVIATION 10.6 • n=7 Participants
18.2 units on a scale
STANDARD_DEVIATION 12.5 • n=5 Participants
18.0 units on a scale
STANDARD_DEVIATION 12.5 • n=4 Participants

PRIMARY outcome

Timeframe: Baseline to Final Training (6 weeks)

Population: The number of participants analyzed were based on an intention to treat methodology with the exception of individuals that were non-compliant with the protocol or did not progress to the midpoint (3 week) evaluation.

The Fugl-Meyer Assessment (FMA) is a stroke-specific, performance-based impairment index. It is designed to assess motor functioning, balance, sensation and joint functioning in patients with post-stroke hemiplegia (Fugl-Meyer, Jaasko, Leyman, Olsson, \& Steglind, 1975; Gladstone, Danells, \& Black, 2002). Sections can be administered separately and the upper extremity motor portion of this measure was used as our primary outcome. Assessment items included movement, coordination, and reflex action of the shoulder, elbow, forearm, wrist, and hand. These items were scored on the basis of ability to complete using a 3-point ordinal scale where 0=cannot perform, 1=performs partially and 2=performs fully. The total possible score for the upper extremity is 66 with a minimum range of 0 and maximum of 66. A higher score indicates a better outcome.

Outcome measures

Outcome measures
Measure
Planar Robot
n=20 Participants
Planar Robot Exercise x 60 minutes.
Planar + Vertical
n=21 Participants
Planar + Vertical Robot Exercise x 60 minutes.
Intensive Conventional Exercise
n=21 Participants
Upper extremity stretching, skateboard reaching activities, range of motion, and arm ergometer training x 60 minutes.
Upper Extremity Portion of the Fugl-Meyer Motor Performance Assessment
3.27 units on a scale
Standard Deviation 3.27
2.51 units on a scale
Standard Deviation 3.33
1.82 units on a scale
Standard Deviation 4.24

Adverse Events

Planar Robot

Serious events: 0 serious events
Other events: 2 other events
Deaths: 0 deaths

Planar + Vertical Robot

Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths

Intensive Conventional Exercise

Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Planar Robot
n=20 participants at risk
Planar Robot Exercise Group
Planar + Vertical Robot
n=21 participants at risk
Planar + Vertical Robot Exercise Group
Intensive Conventional Exercise
n=21 participants at risk
Upper extremity stretching, skateboard reaching activities, range of motion and arm ergometer training.
General disorders
Hospitalization
10.0%
2/20 • Number of events 2 • Adverse event data was collected over a 6 month time period for each participant which included baseline testing, intervention and retention.
4.8%
1/21 • Number of events 1 • Adverse event data was collected over a 6 month time period for each participant which included baseline testing, intervention and retention.
0.00%
0/21 • Adverse event data was collected over a 6 month time period for each participant which included baseline testing, intervention and retention.
Musculoskeletal and connective tissue disorders
Shoulder pain
0.00%
0/20 • Adverse event data was collected over a 6 month time period for each participant which included baseline testing, intervention and retention.
0.00%
0/21 • Adverse event data was collected over a 6 month time period for each participant which included baseline testing, intervention and retention.
4.8%
1/21 • Number of events 1 • Adverse event data was collected over a 6 month time period for each participant which included baseline testing, intervention and retention.

Additional Information

Dr. Susan S. Conroy

VA Maryland Health Care System, Baltimore

Phone: (410) 605-7000

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place